IRIS
BIANCHI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 89.863
AS - Asia 15.702
EU - Europa 11.293
SA - Sud America 2.077
AF - Africa 216
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 36
Totale 119.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 89.290
SG - Singapore 8.066
IT - Italia 3.041
CN - Cina 2.738
RU - Federazione Russa 1.768
BR - Brasile 1.721
HK - Hong Kong 1.294
VN - Vietnam 1.159
IE - Irlanda 1.145
DE - Germania 1.083
FR - Francia 863
UA - Ucraina 819
BD - Bangladesh 663
GB - Regno Unito 644
SE - Svezia 456
JP - Giappone 431
FI - Finlandia 408
CA - Canada 376
IN - India 307
PL - Polonia 292
NL - Olanda 255
KR - Corea 250
AR - Argentina 136
ID - Indonesia 132
ES - Italia 109
MX - Messico 105
AT - Austria 87
TR - Turchia 85
IQ - Iraq 79
UZ - Uzbekistan 77
ZA - Sudafrica 73
EC - Ecuador 65
BE - Belgio 59
AU - Australia 54
MY - Malesia 51
CO - Colombia 44
PH - Filippine 41
LT - Lituania 38
PK - Pakistan 38
AE - Emirati Arabi Uniti 37
EG - Egitto 37
RO - Romania 35
SA - Arabia Saudita 33
IL - Israele 29
KG - Kirghizistan 28
MA - Marocco 28
CL - Cile 27
CH - Svizzera 26
EU - Europa 25
JO - Giordania 24
PY - Paraguay 23
CZ - Repubblica Ceca 22
PE - Perù 22
IR - Iran 21
VE - Venezuela 21
PT - Portogallo 20
TH - Thailandia 20
TN - Tunisia 19
AZ - Azerbaigian 16
DZ - Algeria 16
SK - Slovacchia (Repubblica Slovacca) 16
HU - Ungheria 15
UY - Uruguay 15
JM - Giamaica 14
GR - Grecia 13
NP - Nepal 13
RS - Serbia 13
CR - Costa Rica 12
DK - Danimarca 12
DO - Repubblica Dominicana 12
KE - Kenya 11
HR - Croazia 10
LB - Libano 10
NI - Nicaragua 10
TW - Taiwan 10
PA - Panama 9
HN - Honduras 8
KZ - Kazakistan 8
TT - Trinidad e Tobago 8
ET - Etiopia 7
OM - Oman 7
PR - Porto Rico 7
AL - Albania 6
GE - Georgia 6
SY - Repubblica araba siriana 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GH - Ghana 5
LV - Lettonia 5
NO - Norvegia 5
SN - Senegal 5
AO - Angola 4
BH - Bahrain 4
GT - Guatemala 4
LK - Sri Lanka 4
SC - Seychelles 4
BB - Barbados 3
BO - Bolivia 3
CY - Cipro 3
Totale 119.193
Salva come PNG Salva come JPEG
Città #
Wilmington 23.091
Houston 21.923
Woodbridge 17.401
Singapore 3.466
Fairfield 3.254
Ashburn 2.342
Chandler 1.871
San Jose 1.782
Seattle 1.356
Ann Arbor 1.301
Hong Kong 1.266
Cambridge 1.199
Dublin 1.044
Beijing 981
Council Bluffs 758
Medford 740
Rome 672
Jacksonville 647
New York 634
Santa Clara 585
Dearborn 570
The Dalles 567
Los Angeles 482
Tokyo 369
Ho Chi Minh City 363
Lawrence 347
Dallas 320
Buffalo 283
Hanoi 283
Lauterbourg 262
Zhengzhou 257
Moscow 251
Milan 235
San Diego 227
Menlo Park 200
Boardman 180
Munich 178
Kraków 162
São Paulo 161
Helsinki 147
Chicago 145
London 128
Orem 118
Montreal 116
Redwood City 110
Nuremberg 104
Toronto 103
Redondo Beach 95
Atlanta 92
Shanghai 92
Warsaw 91
Chennai 86
Seoul 85
Lappeenranta 82
Jakarta 81
Brooklyn 77
Frankfurt am Main 76
Mülheim 74
Denver 70
Naples 70
Cedarhurst 65
Amsterdam 64
North Bergen 63
Norwalk 62
Guangzhou 57
Brussels 53
Haiphong 52
Nanjing 52
Salt Lake City 51
Rio de Janeiro 50
Hefei 49
Phoenix 49
Johannesburg 48
Stockholm 48
Da Nang 47
Manchester 47
Boston 46
Colorado Springs 45
Belo Horizonte 43
San Francisco 43
Florence 42
Falls Church 41
San Mateo 40
Verona 39
Engelhard 38
Elk Grove Village 37
Paris 37
Detroit 36
Vienna 36
Bologna 34
Columbus 34
Mexico City 33
Mountain View 31
Mumbai 31
Nanchang 31
Poplar 31
Charlotte 30
Dhaka 29
Porto Alegre 29
Esslingen am Neckar 28
Totale 95.773
Salva come PNG Salva come JPEG
Nome #
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data 1.641
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.396
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.227
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 771
Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions 761
Psoriasiform sarcoidosis: an unusual variety 704
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 696
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 623
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 583
Is weekly dose of adalimumab a simple approach for resistant psoriasis? 555
Efficacy and safety of infliximab in psoriatic patients over the age of 65 552
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. 534
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 532
Leflunomide-induced DRESS syndrome 529
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 509
Topical lactoferrin can improve stable psoriatic plaque 501
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 501
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 501
Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis 495
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 490
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. 485
Angiosarcoma cutaneo epitelioide 484
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 483
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry. 483
Apremilast for the treatment of psoriasis. 477
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 473
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 469
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 465
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 464
Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review 464
Tazarotene as alternative topical treatment for onychomycosis 463
Actinic keratosis treated with an immune response modifier: a case report of six patients 460
Cheratodermia puntata porocheratosica 460
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 458
Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis 458
Treatment of trachyonychia with tazarotene 457
Psodisk, a new visual method for assessing the burden of psoriasis on patients 454
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 454
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 451
Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast 447
Treatment of kerion with fluconazole [30] 443
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 443
Pachydermoperiostosis: Study of epidermal growth factor and steroid receptors 442
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 441
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 440
Brodalumab for the treatment of psoriasis 439
Stress reactivity in psoriatic patients 437
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 437
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 436
Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids 436
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis 436
Phrynoderma: a cutaneous sign of an inadequate diet 434
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 433
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 432
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 428
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 426
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 426
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features 423
Tildrakizumab for treating psoriasis 423
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 422
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 421
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis 421
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 420
Non-familial porphyria cutanea tarda: a case report of a rare disease 420
Severe acne successfully treated with etanercept 419
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 419
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 417
Abnormal bcl-2 and 'tissue' transglutaminase expression in psoriatic skin 413
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 413
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients 413
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 411
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 411
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 411
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 411
Quality-of-life impairment in hidradenitis suppurativa 410
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 407
Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner 406
Confocal reflectance microscopy in pityriasis rubra pilaris 406
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections 406
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 405
Elementi di dermatologia 404
Erysipeloid cutaneous metastasis from bladder carcinoma 402
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 402
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 402
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 401
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 399
Tofacitinib for the treatment of psoriasis 399
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 398
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 398
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 398
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 396
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 396
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis 395
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 395
Mixoma intramuscolare del volto 394
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 394
Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients. 394
Expression and potential role of cellular retinol binding protein I in psoriasis 394
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 393
Totale 48.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 326.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 326.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 0 0 0 0 0 0 277
2021/20223.947 203 434 264 176 177 306 311 188 263 311 285 1.029
2022/20235.053 487 585 198 611 457 1.113 421 285 465 74 232 125
2023/20242.278 247 69 139 72 182 424 225 183 53 192 93 399
2024/202512.242 332 2.047 1.127 652 250 848 808 556 1.032 962 2.057 1.571
2025/202620.273 1.477 807 2.148 1.549 1.639 697 2.512 2.243 2.388 1.889 1.752 1.172
Totale 121.934